The purpose of this study is to compare the effects of the research medicine, solrikitug, with a placebo to find out which is better for treating eosinophilic esophagitis (EoE) in adult patients. The purpose is to see if the research medicine helps improve EoE symptoms: dysphagia (difficulty swallowing), tissue inflammation, clinical symptoms and quality of life.
Thank you for your interest, but this study is not currently enrolling.
United States (Nationwide), International (Worldwide)
Evan Dellon
Medicine-Gastroenterology
Clinical or Medical
Interventional
Allergy
Chronic Conditions
Stomach, Digestion and Gut Health
Rare Diseases
Women's Health
Men's Health
24-1306
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
